Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Sedation with dexmedetomidine in elderly patients during dental surgery: a retrospective case series

  • Seto, Mika (Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Fukuoka University) ;
  • Kita, Ryosuke (Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Fukuoka University) ;
  • Kondo, Seiji (Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Fukuoka University)
  • Received : 2018.07.30
  • Accepted : 2018.10.16
  • Published : 2019.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The number of elderly patients with systemic basal disease requiring invasive dental treatment has increased. Appropriate prediction of surgical invasiveness and combined use of psychosedation are thought to contribute to safe whole-body management. Dexmedetomidine (DEX) exhibits analgesic and anti-anxiolytic properties and causes mild respiratory depression. Studies regarding DEX use in elderly non-intubated patients are scarce. We aimed to use retrospective data to determine an effective dose of DEX to induce adequate sedation in elderly patients undergoing invasive dental surgery under local anesthesia. Materials and Methods: One hundred two patients aged 70 to 96 years were presumably appropriately controlled with sedation. DEX was administered at an initial loading dose of 2.0 to $3.1{\mu}g/kg/hr$ for 10 minutes. We divided the patients into five groups by age and compared their blood pressures and heart rates. Results: In all five groups, blood pressure decreased suddenly at approximately 15 and 20 minutes after DEX administration. A marked decrease in blood pressure was noted in patients aged 75 to 79 years. Conclusion: For elderly patients aged 75 years and above, the initial loading dose of DEX needs to be reduced to lower than half that required for young and middle-age adults.

Keywords

References

  1. Cormack JR, Orme RM, Costello TG. The role of alpha2-agonists in neurosurgery. J Clin Neurosci 2005;12:375-8. https://doi.org/10.1016/j.jocn.2004.06.008
  2. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94. https://doi.org/10.1097/00000542-200008000-00016
  3. Constantin JM, Momon A, Mantz J, Payen JF, De Jonghe B, Perbet S, et al. Efficacy and safety of sedation with dexmedetomidine in critical care patients: a meta-analysis of randomized controlled trials. Anaesth Crit Care Pain Med 2016;35:7-15. https://doi.org/10.1016/j.accpm.2015.06.012
  4. Cillo JE Jr, Finn R. Hemodynamics in elderly coronary artery disease patients undergoing propofol sedation. J Oral Maxillofac Surg 2006;64:1338-42. https://doi.org/10.1016/j.joms.2006.05.018
  5. Taguchi T, Fukuda K, Sekine H, Kakizawa T. Intravenous sedation and hemodynamic changes during dental implant surgery. Int J Oral Maxillofac Implants 2011;26:1303-8.
  6. Hegde S, Padmanabha S, Bhat GK. A comparison of hemodynamic responses and patient comfort in catract surgery with and without midazolam as sedation. IOSR J Dent Med Sci 2014;13:23-7. https://doi.org/10.9790/0853-13112327
  7. Silva-Jr JM, Katayama HT, Nogueira FAM, Moura TB, Alves TL, de Oliveira BW. Comparison of dexmedetomidine and benzodiazepine for intraoperative sedation in elderly patients: a randomized clinical trial. Reg Anesth Pain Med 2019;44:319-24. https://doi.org/10.1136/rapm-2018-100120
  8. Kanto JH. Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia. Pharmacotherapy 1985;5:138-55. https://doi.org/10.1002/j.1875-9114.1985.tb03411.x
  9. MacLaren R, Preslaski CR, Mueller SW, Kiser TH, Fish DN, Lavelle JC, et al. A randomized, double-blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short-term psychological outcomes. J Intensive Care Med 2015;30:167-75. https://doi.org/10.1177/0885066613510874
  10. Kunisawa T, Hanada S, Kurosawa A, Suzuki A, Takahata O, Iwasaki H. Dexmedetomidine was safely used for sedation during spinal anesthesia in a very elderly patient. J Anesth 2010;24:938-41. https://doi.org/10.1007/s00540-010-1025-z
  11. Shah RR. Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II). Br J Clin Pharmacol 2004;58:452-69. https://doi.org/10.1111/j.1365-2125.2004.02228.x
  12. Ok HG, Baek SH, Baik SW, Kim HK, Shin SW, Kim KH. Optimal dose of dexmedetomidine for sedation during spinal anesthesia. Korean J Anesthesiol 2013;64:426-31. https://doi.org/10.4097/kjae.2013.64.5.426
  13. Kim J, Kim WO, Kim HB, Kil HK. Adequate sedation with singledose dexmedetomidine in patients undergoing transurethral resection of the prostate with spinal anaesthesia: a dose-response study by age group. BMC Anesthesiol 2015;15:17. https://doi.org/10.1186/1471-2253-15-17

Cited by

  1. Dexmedetomidine : Persistent hypotension and bradycardia: 4 case reports vol.1767, pp.1, 2019, https://doi.org/10.1007/s40278-019-66490-7